ACA
TMDX icon

Atlas Capital Advisors’s Transmedics TMDX Stock Holding History

Atlas Capital Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.7K Hold
500
– – 0.01% 645
2025
Q4 		$60.8K Buy
+500
New +$62.7K 0.01% 598
2025
Q2 		$67K Hold
500
– – 0.01% 588
2025
Q1 		$33.6K Hold
500
– – ﹤0.01% 673
2024
Q4 		$31.2K Buy
+500
New +$46.5K ﹤0.01% 673

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Atlas Capital Advisors's TMDX Position: Q1 2026 in Review

Atlas Capital Advisors held its Transmedics (TMDX) position steady in Q1 2026 at 500 shares worth $49.7K. The position accounts for 0.01% of the portfolio, ranked #645.

Atlas Capital Advisors first reported a position in TMDX in Q4 2024 and has held it in 5 quarters since. The position peaked at $67K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Atlas Capital Advisors held 500 shares of Transmedics worth $49.7K as of Q1 2026.
  • Atlas Capital Advisors left its Transmedics share count unchanged in Q1 2026.
  • Transmedics made up 0.01% of Atlas Capital Advisors's portfolio in Q1 2026, its #645 holding.
  • Atlas Capital Advisors first reported a position in Transmedics in Q4 2024 and has held it in 5 quarters since.
  • Atlas Capital Advisors's Transmedics position peaked at $67K in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.